
It is important to increase the diversity of clinical-trial participants because there is growing evidence that gender and ethnicity play important roles in health care outcomes. Not only are certain groups at higher risk for specific diseases, but race and ethnicity play a role in how patients respond to drugs.
Read Increasing Diversity in Clinical Trials Can Save Lives (Op-Ed)
by Dr. Bruce Moskowitz, LiveScience, 01 July 2013.
Our posts tagged All Trials – Pharmaceutical industry.
Reblogged this on Laitom's Blog.
Tom
thanks Tom